Literature DB >> 10090130

Serum leptin levels in males with delayed puberty during short-term pulsatile GnRH administration.

M Giusti1, R Guido, S Valenti, G Giordano.   

Abstract

Leptin may be a possible trigger for puberty. In normal males, it has been shown that leptin increases from the pre-pubertal to the early pubertal stage, and then declines in the late pubertal stage. We examined leptin levels in six male adolescents (mean age 16.3+/-0.6 yr; range 14.2-17.6 yr) with delayed puberty (constitutional delay of puberty no.=2; idiopathic hypogonadotropic hypogonadism no.=4) during 120 days of subcutaneous pulsatile GnRH administration. A group of subjects in pre-puberty (no.=11), early-puberty (n=10) and mid-puberty (no.=7) were evaluated as controls. Morning blood samples were taken for determination of leptin, testosterone, LH and FSH levels. In delayed puberty subjects blood samples were taken every 30 days after the start of GnRH administration. At each examination BMI and testicular volume were evaluated. A follow-up examination was performed in the 6 patients 1.3-7.5 yr after the end of the 120 days of GnRH therapy. At baseline evaluation in delayed puberty mean leptin levels were 11.3+/-2.0 microg/l (median 11.3 microg/l; range 4.7-17.3 microg/l) and were higher than those found in pre-puberty (p=0.04) and mid-puberty (p=0.001). During GnRH administration there was no change in BMI and leptin levels but there was an increase in gonadotrophin levels, testosterone and testicular volume. One hundred and twenty days after, mean serum leptin were 10.1+/-2.1 microg/l (median 9.1 microg/l; range 3.4-16.8 microg/l). At the end of the study, leptin levels were higher in delayed puberty than in mid-puberty (p=0.002). At the follow-up examination leptin levels were 4.3+/-1.3 microg/l (median 3.4 microg/l; range 1.4-9.1 microg/l) (p=0.03 vs end of 120 days GnRH therapy) while testosterone and BMI were not changed. In conclusion 120-day pulsatile GnRH administration induced in males with delayed puberty physiological-like pubertal changes but not the decline in leptin levels reported during the progression of puberty. Therefore, in males with delayed puberty an impairment in the phenomenon of leptin decline associated with progression of puberty could be suggested. However after retrospective diagnosis of pubertal delay and long-term therapy in subjects with idiopathic hypogonadotropic hypogonadism leptin levels declined. These data seem to indicate that time more than increase in testosterone levels and testicular volume is the determinant of leptin decline at puberty.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090130     DOI: 10.1007/BF03345471

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Contribution of androgens to the gender difference in leptin production in obese children and adolescents.

Authors:  M Wabitsch; W F Blum; R Muche; M Braun; F Hube; W Rascher; E Heinze; W Teller; H Hauner
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Early onset of reproductive function in normal female mice treated with leptin.

Authors:  F F Chehab; K Mounzih; R Lu; M E Lim
Journal:  Science       Date:  1997-01-03       Impact factor: 47.728

3.  Leptin in puberty.

Authors:  D Apter
Journal:  Clin Endocrinol (Oxf)       Date:  1997-08       Impact factor: 3.478

4.  A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty.

Authors:  C S Mantzoros; J S Flier; A D Rogol
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

5.  Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone.

Authors:  A Giustina; T Scalvini; C Tassi; P Desenzani; C Poiesi; W B Wehrenberg; A D Rogol; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1997-04       Impact factor: 5.958

6.  Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone.

Authors:  W F Blum; P Englaro; S Hanitsch; A Juul; N T Hertel; J Müller; N E Skakkebaek; M L Heiman; M Birkett; A M Attanasio; W Kiess; W Rascher
Journal:  J Clin Endocrinol Metab       Date:  1997-09       Impact factor: 5.958

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Delayed puberty in uremia: pituitary-gonadal function during short-term pulsatile luteinizing hormone-releasing hormone administration.

Authors:  M Giusti; F Perfumo; E Verrina; D Cavallero; G Piaggio; S Valenti; R Gusmano; G Giordano
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

9.  Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.

Authors:  D S Weigle; T R Bukowski; D C Foster; S Holderman; J M Kramer; G Lasser; C E Lofton-Day; D E Prunkard; C Raymond; J L Kuijper
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

10.  Weight-reducing effects of the plasma protein encoded by the obese gene.

Authors:  J L Halaas; K S Gajiwala; M Maffei; S L Cohen; B T Chait; D Rabinowitz; R L Lallone; S K Burley; J M Friedman
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  2 in total

1.  Decrease of serum leptin levels in adult male with idiopathic hypogonadotropic hypogonadism (IHH) treated with pulsatile gonadotropin-releasing hormone (GnRH).

Authors:  D Macut; D Micić; S Zorić; M Sumarac; A Kendereski; G Cvijović; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Loss of PI3K p110α in the Adipose Tissue Results in Infertility and Delayed Puberty Onset in Male Mice.

Authors:  Victoria L Boughton Nelson; Ariel L Negrón; Inefta Reid; Justin A Thomas; Leon Yang; Richard Z Lin; Maricedes Acosta-Martínez
Journal:  Biomed Res Int       Date:  2017-03-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.